3 Dividend Stocks to Hold for the Next 20 Years

Source The Motley Fool

Key Points

  • Chevron operates in all three phases of the oil value chain.

  • Procter & Gamble has increased its annual dividend for 69 consecutive years.

  • Johnson & Johnson spun off its consumer division to focus on pharmaceuticals and medical devices.

  • 10 stocks we like better than Chevron ›

For many people, "I invest in dividend stocks" doesn't have the same ring to it as investing in "the next big thing." But the former can often be just as lucrative, if not more so. Even relatively small dividends compound and add up over the years.

There's also a peace that comes with knowing that you'll be rewarded for holding a stock regardless of how its price moves. That's why you shouldn't just go searching for high yields; you should invest in companies built to maintain their dividend for the long haul. That's how you truly get the most value from your dividend stocks.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

If you're looking to add dividend stocks to your portfolio, each of the following three options is a go-to you can confidently hold for the next 20 years.

A sign with "DIVIDENDS" written on it near a coin jar and money.

Image source: Getty Images.

1. Chevron

Chevron (NYSE: CVX) is the second-largest U.S. oil company, operating across three main segments of the value chain: upstream, midstream, and downstream. Upstream involves exploration and extraction; midstream involves transportation, processing, and storing; and downstream involves refining products and selling them to consumers.

Having a hand in all three segments helps Chevron weather segment-specific downturns, price swings, and disruptions caused by geopolitical events. It's not foolproof, but it's better than relying on one part of the oil business in many cases.

Over the past decade, Chevron has averaged a dividend yield of around 4.2%, more than 2.5 times the S&P 500 average in that span. It provides high income and stability, with 38 consecutive years of annual payout increases.

CVX Dividend Yield Chart

CVX Dividend Yield, data by YCharts.

The oil industry can be cyclical, but you don't have to worry about Chevron's dividend at any point. Its finances comfortably support the dividend, and it has said it's committed to running a more efficient operation. This includes prioritizing profits over expansion and aiming to maximize shareholder returns.

If you're investing for the long haul, you usually can't go wrong with a cash-flow-heavy business with financial discipline.

2. Procter & Gamble

Even if the name Procter & Gamble (NYSE: PG) does not ring a bell for anyone, the products that it owns probably will. In its portfolio, it has notable brands like Tide, Pampers, Old Spice, Febreze, Crest, and dozens of others.

P&G is a poster child for defensive and recession-proof stocks because it owns products that sell no matter what. If it's a recession and money is tight, people will cut back on a lot of things before they stop buying laundry detergent, disposable diapers, and toothpaste.

You won't get explosive earnings or stock growth from P&G, but you'll get dependability, both with its finances and dividend. It's a Dividend King, a company with at least 50 consecutive years of payout increases. In fact, it has 69 consecutive years under its belt. There are only five companies on the U.S. stock market with a longer streak.

Procter & Gamble might be a "boring" stock, but those are often the ones you feel comfortable holding for decades. Flashy isn't always sustainable.

3. Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) is one of the largest healthcare companies in the world, but its business looks much different now than it did just two and a half years ago. In August 2023, it spun off its consumer division (which included products such as Tylenol and Band-Aids) and focused on pharmaceuticals and medical devices.

Even with the restructuring, it has hardly missed a beat. Revenue dropped in 2023 because of the spinoff, but it has been a good two years since then. Revenue was $94.2 billion in 2025, up 6% from 2024 and 17% since 2023. It's modest growth, but that's all you can ask for in a company as mature and big as Johnson & Johnson.

JNJ Revenue (Annual) Chart

JNJ Revenue (Annual) data by YCharts.

Similar to P&G, Johnson & Johnson has necessity working in its favor, except it's not hygiene or cleaning products, it's healthcare. Chronic diseases and age-related conditions are here to stay. They're unfortunate, but they're also responsible for the company's longevity.

The healthcare landscape will look different 20 years from now, but you can bet Johnson & Johnson will have its hand in it. You can also bet that its dividend will still be going strong. It's currently on its 63rd consecutive year of annual increases.

Should you buy stock in Chevron right now?

Before you buy stock in Chevron, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Chevron wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $462,174!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,143,099!*

Now, it’s worth noting Stock Advisor’s total average return is 946% — a market-crushing outperformance compared to 196% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of January 28, 2026.

Stefon Walters has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Chevron. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold moves away from record high as safe-haven demand fades on easing trade war concernsGold (XAU/USD) is seen extending the previous day's modest pullback from the vicinity of the $4,900 mark, or a fresh all-time peak, and drifting lower through the Asian session on Thursday.
Author  FXStreet
Jan 22, Thu
Gold (XAU/USD) is seen extending the previous day's modest pullback from the vicinity of the $4,900 mark, or a fresh all-time peak, and drifting lower through the Asian session on Thursday.
placeholder
Gold Price Forecast: XAU/USD gains momentum to near $5,050 amid geopolitical risks, Fed uncertaintyGold price (XAU/USD) extends its upside to around $5,050 during the early Asian session on Tuesday. The precious metal gains momentum amid growing concerns about financial and geopolitical uncertainty. The US ADP Employment Change and Consumer Confidence reports will be published later on Tuesday.
Author  FXStreet
Yesterday 01: 32
Gold price (XAU/USD) extends its upside to around $5,050 during the early Asian session on Tuesday. The precious metal gains momentum amid growing concerns about financial and geopolitical uncertainty. The US ADP Employment Change and Consumer Confidence reports will be published later on Tuesday.
placeholder
Santiment Says XRP and Ethereum Look “Undervalued” on 30-Day MVRVSantiment says XRP and Ethereum sit in a 30-day MVRV “undervalued” zone, with XRP at -5.7% and ETH at -7.6%, while Bitcoin is listed at 3.7% and XRP has rebounded above $1.9 after dipping to $1.8 on Sunday.
Author  Mitrade
Yesterday 06: 22
Santiment says XRP and Ethereum sit in a 30-day MVRV “undervalued” zone, with XRP at -5.7% and ETH at -7.6%, while Bitcoin is listed at 3.7% and XRP has rebounded above $1.9 after dipping to $1.8 on Sunday.
placeholder
Bitcoin’s ‘Bottoming Phase’ Ends: Five Key Things to Watch This WeekBitcoin struggles with precarious positioning amidst macroeconomic volatility, closing the week below key support and setting the stage for potential further declines.
Author  Mitrade
Yesterday 09: 52
Bitcoin struggles with precarious positioning amidst macroeconomic volatility, closing the week below key support and setting the stage for potential further declines.
placeholder
Top 3 Price Outlook: BTC Holds Above $89,000 as ETH Tests Resistance and XRP Stabilizes Near $1.90BTC trades near $89,300 after reclaiming $87,787 support and eyes $90,000, while ETH tests $3,017 and the $3,101 50-day EMA and XRP rebounds to $1.90 from $1.83 with $1.96 resistance and $1.77 downside risk.
Author  Mitrade
6 hours ago
BTC trades near $89,300 after reclaiming $87,787 support and eyes $90,000, while ETH tests $3,017 and the $3,101 50-day EMA and XRP rebounds to $1.90 from $1.83 with $1.96 resistance and $1.77 downside risk.
goTop
quote